Clinical Trials Directory

Trials / Completed

CompletedNCT03302039

Three Protocols for Phenylephrine Administration in Cesarean Delivery

Three Protocols for Phenylephrine Administration for Prophylaxis Against Post-spinal Hypotension During Cesarean Delivery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
217 (actual)
Sponsor
Cairo University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single shot (1.5 mcg/Kg) phenylephrine.

Detailed description

Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Phenylephrine (PE) is the most popular vasopressor for prevention of post-spinal hypotension (PSH) during CD; however, the most appropriate protocol for PE administration is still unknown. The most common PE protocols used for prophylaxis against PSH are: single shot, fixed infusion, and variable infusion. A recent study reported that a dose of 1.5 mcg/Kg is the most suitable single-shot dose for prophylaxis. Another randomized controlled trial compared four doses of PE infusion and reported that 25 mcg/Kg/min and 50 mcg/Kg/min doses were the best doses for fixed infusion with accepted incidence of both PSH as well as reactive hypertension. Using variable infusion rate of PE had been recently introduced in another study with a starting dose of 0.75 mcg/Kg/min. The variable rate infusion showed very good results regarding PSH. In this study, the investigators will compare variable infusion of PE (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop if reactive hypertension occurred) and single shot protocol (1.5 mcg/Kg).

Conditions

Interventions

TypeNameDescription
DRUGSingle shot phenylephrineA single shot of phenylephrine (1.5 mcg/Kg) will be administrated intravenously.
DRUGFixed infusion phenylephrine.Fixed infusion of phenylephrine will be administrated at a rate of 0.75 mcg/Kg/min
DRUGVariable infusion phenylephrine.Variable infusion of phenylephrine will be administrated at a starting rate of 0.75 mcg/Kg/min.
DRUGBupivacaineBupivacaine will be administrated in the subarachnoid space for spinal anesthesia.

Timeline

Start date
2017-10-06
Primary completion
2018-10-01
Completion
2018-10-15
First posted
2017-10-04
Last updated
2018-12-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03302039. Inclusion in this directory is not an endorsement.